PPHM - Peregrine Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.86
-0.21 (-5.16%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.07
Open4.00
Bid3.81 x 100
Ask4.21 x 400
Day's Range3.82 - 4.00
52 Week Range1.96 - 5.78
Volume324,779
Avg. Volume219,485
Market Cap174.521M
Beta3.14
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : December 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q2, 2018 By the Numbers : December 13, 2017
    Capital Cube4 days ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q2, 2018 By the Numbers : December 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Peregrine Pharmaceuticals, Inc. reports financial results for the quarter ended October 31, 2017. We analyze the earnings along side the following peers of Peregrine Pharmaceuticals, Inc. – Merck & Co., Inc., Madrigal Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Fennec Pharmaceuticals Inc. and Celldex Therapeutics, Inc. (MRK-US, ... Read more (Read more...)

  • Company News For Dec 13, 2017
    Zacks4 days ago

    Company News For Dec 13, 2017

    Companies in the news are: GLYC,KMG,PAY,PPHM

  • GuruFocus.com4 days ago

    2 Stocks Fall Tuesday

    Peregrine Pharmaceuticals, Casey's General Stores missed earnings expectations

  • Thomson Reuters StreetEvents5 days ago

    Edited Transcript of PPHM earnings conference call or presentation 11-Dec-17 9:30pm GMT

    Q2 2018 Peregrine Pharmaceuticals Inc Earnings Call

  • Associated Press5 days ago

    Peregrine reports 2Q loss

    The Tustin, California-based company said it had a loss of 31 cents per share. Losses, adjusted for restructuring costs, came to 27 cents per share. The pharmaceutical posted revenue of $12.8 million in ...

  • 3 Drug Stocks That Soared This Week: Are They Buys?
    Motley Fool14 days ago

    3 Drug Stocks That Soared This Week: Are They Buys?

    Can Catalyst, Sucampo, and Peregrine keep the momentum going?

  • Capital Cube2 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : October 23, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : September 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube3 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017
    Capital Cube3 months ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Peregrine Pharmaceuticals, Inc. reports financial results for the quarter ended July 31, 2017. We analyze the earnings along side the following peers of Peregrine Pharmaceuticals, Inc. – Merck & Co., Inc., Madrigal Pharmaceuticals, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Fennec Pharmaceuticals Inc. and Celldex Therapeutics, Inc. (MRK-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of PPHM earnings conference call or presentation 11-Sep-17 8:30pm GMT

    Q1 2018 Peregrine Pharmaceuticals Inc Earnings Call

  • Associated Press3 months ago

    Peregrine reports 1Q loss

    The Tustin, California-based company said it had a loss of 6 cents per share. The pharmaceutical posted revenue of $27.1 million in the period. Peregrine expects full-year revenue in the range of $50 million ...

  • Capital Cube4 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : August 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of PPHM earnings conference call or presentation 14-Jul-17 8:30pm GMT

    Q4 2017 Peregrine Pharmaceuticals Inc Earnings Call

  • Capital Cube4 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : August 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q4, 2017 By the Numbers : July 19, 2017
    Capital Cube5 months ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q4, 2017 By the Numbers : July 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Peregrine Pharmaceuticals, Inc. reports financial results for the quarter ended April 30, 2017. Highlights Summary numbers: Revenues of USD 17.90 million, Net Earnings of USD -5.27 million. Gross margins narrowed from 48.25% to 34.19% compared to the same period last year, operating (EBITDA) margins now -26.20% from -60.17%. Change in operating ... Read more (Read more...)

  • Associated Press5 months ago

    Peregrine reports 4Q loss

    The Tustin, California-based company said it had a loss of 16 cents per share. The pharmaceutical posted revenue of $17.9 million in the period. For the year, the company reported that its loss narrowed ...

  • Top 10 Penny Stocks To Buy in 2017
    Insider Monkey6 months ago

    Top 10 Penny Stocks To Buy in 2017

    What are the top 10 penny stocks to buy in 2017? Out of thousands of stocks that are trading at price levels below $1.00, it can be hard to identify winning picks, especially since it’s no secret that the companies behind penny stocks may be involved in scams or other shady endeavors that will cause […]

  • Zacks7 months ago

    Implied Volatility Surging for Peregrine Pharmaceuticals (PPHM) Stock Options

    Peregrine Pharmaceuticals (PPHM) warrants investors' attention based on moves in the options market lately.

  • Capital Cube7 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : May 2, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube8 months ago

    ETFs with exposure to Peregrine Pharmaceuticals, Inc. : April 11, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Peregrine Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PPHM-US. Comparing the performance and risk of Peregrine Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017
    Capital Cube9 months ago

    Peregrine Pharmaceuticals, Inc. :PPHM-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017

    Categories: Yahoo Finance Get free summary analysis Peregrine Pharmaceuticals, Inc. reports financial results for the quarter ended January 31, 2017. We analyze the earnings along side the following peers of Peregrine Pharmaceuticals, Inc. – Merck & Co., Inc., Pfizer Inc., Eli Lilly and Company, OncoGenex Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Celldex Therapeutics, Inc. (MRK-US, PFE-US, LLY-US, OGXI-US, ... Read more (Read more...)